NR-axspa

Clinical trials for NR-axspa explained in plain language.

Never miss a new study

Get alerted when new NR-axspa trials appear

Sign up with your email to follow new studies for NR-axspa, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Completed 1

New drug aims to ease back pain and stiffness for arthritis patients

Symptom relief Not yet recruiting

This study tests whether the drug vilamakitug can reduce symptoms of axial spondyloarthritis, a type of arthritis that causes back pain and stiffness. About 150 adults with active disease will receive either the drug or a placebo. The main goal is to see if more people get at lea…

Matched conditions: NR-AXSPA

Phase 2 • Sponsor: XBiotech, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 12:33 UTC

NR-axspa

Get alerted when new NR-axspa trials appear

New drug aims to ease back pain and stiffness for arthritis patients